![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
Oxygen Biotherapeutics Announces Registered Financing for up to $7.5 Million in Gross Proceeds
December 09, 2011 08:35 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., Dec. 9, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT) today announced that it has entered into definitive agreements with institutional investors...
![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
Oxygen Biotherapeutics to Present at 23rd Annual Piper Jaffray Healthcare Conference
November 22, 2011 11:20 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., Nov. 22, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT) today announced that Chief Financial Officer and Interim CEO Michael Jebsen will present at...
![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
Oxygen Biotherapeutics to Voluntarily Withdraw Secondary Listing From SIX Swiss Stock Exchange
October 27, 2011 16:45 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., Oct. 27, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT) today announced that the SIX Swiss Stock Exchange has approved the application filed by the...
![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
Oxygen Biotherapeutics Names Dr. Ronald Blanck Chairman of the Board
September 30, 2011 17:59 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., Sept. 30, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that Ronald R. Blanck, DO, was appointed Chairman of the...
![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
Oxygen Biotherapeutics Reports First Quarter FY2012 Financial Results and Announces Conference Call and Webcast for Shareholders
September 19, 2011 17:25 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., Sept. 19, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...
![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
Oxygen Biotherapeutics Announces Dismissal of Chris J. Stern as CEO and Appointments of Michael B. Jebsen as Interim CEO and Rene Eckert as Interim Chairman
August 24, 2011 17:15 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., Aug. 24, 2011 (GLOBE NEWSWIRE) -- The Board of Directors of Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that Chris J. Stern is no longer...
![DERMACYTE Summer Rescue Bundle](http://www.globenewswire.com/en/Attachment/LogoDisplay/220155?filename=220155.jpg&size=2)
Photo Release -- Beat the Summertime Skin Blues With Dermacyte(R) Summer Rescue Bundle to Soothe Dry Skin and Bring Back a Youthful Glow
August 01, 2011 09:00 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., Aug. 1, 2011 (GLOBE NEWSWIRE) -- Let's face it: summer is fun, but it can be tough on your skin. Most of us spend more hours outdoors in summer than during any other season doing...
![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
Oxygen Biotherapeutics and Aurum Biosciences Sign Letter of Intent to Explore the Use of Oxycyte(R) PFC for Imaging and Therapeutic Intervention of Acute Ischemic Stroke
July 25, 2011 02:00 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., July 25, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) and privately held Aurum Biosciences, Ltd. of Glasgow, Scotland, today...
![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
Global Interest in the Potential Medical Benefits of Novel Perfluorocarbon At All Time High
July 20, 2011 08:00 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., July 20, 2011 (GLOBE NEWSWIRE) -- University and educational institution researchers from the United Kingdom, Switzerland and the United States all have one thing in common: an...
![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
Oxygen Biotherapeutics Reports Financial Results for Fiscal Year 2011
July 14, 2011 18:02 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., July 14, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...